Augmented Depression Therapy for Depression

This trial tests Augmented Depression Therapy (ADepT) to evaluate its effectiveness in supporting people with depression and to gather participant feedback. ADepT includes 15 weekly therapy sessions, with optional booster sessions over the following year. Participants will be randomly assigned to different research assessment schedules before starting therapy. This trial suits individuals experiencing a major depressive episode who are not currently receiving therapy elsewhere. As an unphased trial, it provides a unique opportunity to contribute to innovative research and potentially benefit from a novel therapeutic approach.

Research has shown that Augmented Depression Therapy (ADepT) is generally safe and manageable. In earlier studies, most participants experienced improvements in both depression and overall health. Importantly, no participants worsened due to the therapy, suggesting it likely does not cause harmful side effects. Some individuals even continued to improve a year after treatment. These findings provide confidence that ADepT is a safe option for those considering this therapy.¹²³⁴⁵

Researchers are excited about Augmented Depression Therapy (ADepT) because it offers a fresh approach to managing depression. Unlike standard treatments like SSRIs or cognitive behavioral therapy, ADepT integrates a systematic baseline assessment phase that tailors the therapy to the individual's specific needs over several weeks. This personalized approach could lead to more effective and quicker symptom relief. Additionally, the structured baseline assessments might help in understanding the patient's unique depression profile, leading to more targeted and effective therapy sessions.

Research has shown that Augmented Depression Therapy (ADepT) can significantly enhance wellbeing and reduce depression symptoms. Studies have found that most participants experience noticeable improvements, with no reports of worsening conditions. In one study, 33% of participants showed clear improvements in their depression symptoms, and 67% felt better overall. ADepT has been compared to Cognitive Behavioral Therapy (CBT) and may be equally or more effective. Additionally, 94% of participants reported they would recommend ADepT to others, indicating high satisfaction. These findings suggest that ADepT could be a promising treatment for depression.¹²³⁴⁵